Benefit of the Oxygen Reserve Index for Control of Success of Preoxygenation in Adults
NCT ID: NCT04596215
Last Updated: 2022-02-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
60 participants
OBSERVATIONAL
2020-12-01
2021-07-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Oxygen Reserve Index for Kids
NCT03845192
Pre-hospital Hypoxemia in Trauma Patients
NCT01074983
A Study of the Effect of Arterial Carbon Dioxide Tension on the Recovery of Spontaneous Respiration
NCT01733446
Pulse Oximetry- Evaluating Resp Rate- PCBA-1
NCT01791582
Brachial Artery Peak Velocity Variation to Predict Fluid Responsiveness
NCT00890071
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* written informed consent
Exclusion Criteria
* Patients with expected difficult airway and indication for an awake fiberoptic intubation and therefore no need of preoxygenation
* no written informed consent
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Johannes Gutenberg University Mainz
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Nina Pirlich, Dr. med.
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Johannes Gutenberg - Universität
Mainz, Rhineland-Palatinate, Germany
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PRIORI 1.0
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.